- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 31.33M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $159.5M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $158.06M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $12.37M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $11.59M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $18.54M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.32M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $198.67M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $198.57M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $117.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $114.93M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $327.79M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $324.14M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $175.97M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $172.47M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $526.79M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $523.04M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 31.36M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $4.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $604K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $36.25M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $343K |
| Net Income | Q1 2025 · Mar 31, 2024 | $995K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $5.55M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $46.15M |
| Revenue | Q1 2025 · Mar 31, 2024 | $184.44M |